oncology

When the Cancer's Origin Is Unknown, a Second Opinion Earns Its Keep

Save

When the primary tumor cannot be located, small differences in how the tissue is read can change everything that follows. This is where a subspecialist's re-review of the slides and imaging earns its keep — and how to arrange one without delaying care or worrying that you have offended the doctor who found it.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What a cancer of unknown primary is

A cancer of unknown primary, or CUP, is a confirmed cancer whose organ of origin cannot be identified even after imaging, biopsy, and a standard workup. Pathologists can see that the cells are malignant and often what tissue they resemble, but the trail back to a lung, breast, pancreas, or other starting site stays cold. Treatment then rests on the best available read of the tissue itself. Cancer of unknown primary (CUP) — a confirmed cancer whose organ of origin is never found.

That is a different situation from a cancer with an obvious source. Here the diagnosis is an act of interpretation — of cells under a microscope and of shadows on a scan — and interpretation is exactly where skilled reviewers can reach different conclusions. The stakes are high, because the presumed origin steers the entire treatment plan.

Why an unknown primary is the case a second opinion is built for

Because everything downstream depends on reading ambiguous tissue and scans, an unknown primary is where a fresh expert eye tends to change the most. Rare and hard-to-classify tumors are exactly the cases where an outside lab and a specialized center most often disagree. Re-reading the material at a high-volume center is not second-guessing — for cases this uncertain, it is closer to standard practice.

In soft-tissue sarcoma, a rare and notoriously hard-to-classify group, one series found initial diagnostic agreement as low as 28% at private clinics, rising to about 70% at the expert center, and expert review confirmed or improved the correct primary diagnosis in 73% of cases 1. A landmark review of more than 6,000 outside slides re-read at a single referral hospital changed the diagnosis in a way that altered treatment or prognosis in 1.4% of them 2. Imaging is re-read too — subspecialists disagreed about whether something was cancer in about 13% of 240 outside PET-CT scans, and where the truth was later known, their read was correct in 89% 3.

The slides and scans get re-read, not just the report

A second opinion worth having re-examines the original glass pathology slides, the paraffin tissue blocks, and the actual imaging files — not merely the typed report. For an unknown primary, that raw material is where a likely origin or a corrected tumor type is most often found. A report tells you only what the first reader concluded; the slides let a second reader reach an independent read.

You have a right to these materials. Patients are entitled to copies of their records and pathology slides, and most oncologists expect the request as a normal part of care 4. You can have the first center send the slides and blocks directly to the reviewing pathology team, or release them to you to carry. At an expert center, additional immunohistochemical stains and, in some cases, molecular profiling of the tumor may be added to narrow the list of likely origins. Ask for the slides and blocks, not just the report — the glass is what a second pathologist actually re-reads.

What a second opinion usually changes, and what it usually doesn't

More often than not, the reviewing team confirms the original diagnosis. The value is usually in refinement — a clearer subtype, a different order of treatment, a clinical trial you qualify for — rather than a reversal. Knowing that in advance keeps the appointment from feeling like a referendum on your first doctor, and makes a 'we agree' outcome feel like the reassurance it is.

The odds of a changed diagnosis rise with how unusual the tissue is. Expert re-review of lymphoma revised the diagnosis in roughly one in six cases overall, and for some subtypes, such as Burkitt lymphoma, the figure reached 75% 5. Even when the diagnosis holds, the plan often shifts: in one oncology review, 35% of cases saw a clinically meaningful change, most of which occurred even when the original diagnosis was confirmed 6. A second opinion that simply agrees is not a wasted visit — for most people, confirmation is the result, and it is a good one.

Where to get an unknown-primary second opinion

For an unknown primary, the natural place to look is a high-volume academic or NCI-designated cancer center, where subspecialty pathologists and multidisciplinary tumor boards handle ambiguous cases regularly. Many now offer remote second opinion programs that review your slides and scans without travel and return a written report, so distance is rarely the barrier it once was.

Comparing the remote programs on turnaround time, cost, and which specialties they cover helps you choose one suited to an unknown primary specifically. If the workup later points toward a likely origin, a diagnosis-specific review — a lung cancer second opinion, a thyroid cancer second opinion, or a gynecologic cancer second opinion — may become the better next step, and a broader cancer second opinion guide covers the logistics they share.

What the reviewing team needs from you

A review runs on the raw materials, so gathering the right packet up front saves weeks. The reviewing program will send a list, but it almost always includes the original glass slides and tissue blocks, a disc or drive holding your CT, MRI, or PET scans, the pathology and radiology reports, and a short summary of the workup done so far. Your first center can ship most of it directly to the reviewers.

Starting the records request early matters more here than for a straightforward cancer, because for an unknown primary the review may want to re-cut the blocks or add stains — steps that need the physical tissue, not a scanned picture of a slide. The sooner the materials are in transit, the sooner the second read can begin.

Will asking for a second opinion offend your oncologist?

Almost never. A second opinion on a serious or ambiguous cancer is an expected part of care, and most oncologists will help arrange one — many suggest it themselves. The worry about giving offense is common and, by professional norms, largely unfounded 4. A doctor confident in the diagnosis has nothing to fear from a second reader; a doctor who bristles has told you something worth knowing.

The one real constraint is time. An unknown primary is usually not a same-day emergency, so a review that takes days to a couple of weeks rarely costs anything — though it is worth asking both teams whether anything in your case is time-sensitive before building in a delay.

Common questions

It is a diagnosis of exclusion. After a biopsy confirms cancer, doctors run imaging, blood work, and tissue stains to hunt for the starting organ. When that search comes up empty, the cancer is labeled 'of unknown primary' and treated based on the cell type and where it has spread, rather than a named origin.

Usually only by days to a couple of weeks, which for a non-emergency cancer is generally an acceptable window. A remote review working from your existing slides and scans can be faster than an in-person visit. It is worth asking both your current team and the reviewing team whether anything in your case is time-sensitive before you schedule.

The materials that let a pathologist re-read the case: the original glass slides and tissue blocks, copies of your imaging on a disc, the pathology and radiology reports, and a summary of your workup so far. The reviewing program will give you a list, and your first center can send items directly to them.

Often not. Many academic centers run remote second opinion programs that review your slides and scans and return a written report without an in-person visit. Travel makes sense when a hands-on exam or a procedure is part of the question, but for re-reading tissue and imaging, distance is rarely the obstacle.

Many plans cover diagnostic and surgical second opinions, and Original Medicare covers a second opinion before medically necessary, non-emergency surgery. Coverage for remote or out-of-network academic programs varies, and some charge a flat fee. Confirming the cost with both your insurer and the program before you commit avoids a surprise bill.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a symptom can't wait for a second opinion

  • —New or fast-worsening shortness of breath, chest pain, or coughing up blood while you wait for a review
  • —New leg weakness, numbness around the groin or inner thighs, or loss of bladder or bowel control — possible spinal cord compression
  • —A fever above the level your team told you to watch for during or after chemotherapy, which can signal a dangerous infection

A second opinion is for non-emergency decisions. For sudden severe symptoms — trouble breathing, chest pain, new weakness, or a high fever during chemotherapy — call 911 or go to the emergency room rather than wait for any review.

This article explains how second opinions work for a cancer of unknown primary. It is educational and not a diagnosis or a treatment plan. Decisions about your care belong to you and the clinicians who can examine you and your records.

References

  1. 1.Lehnhardt M, Daigeler A, Hauser J, Puls A, Soimaru C, Kuhnen C, Steinau HU (2008). The value of expert second opinion in diagnosis of soft tissue sarcomas. Journal of Surgical Oncology. doi:10.1002/jso.20897 ✓That in rare, hard-to-classify tumors like soft-tissue sarcoma, initial diagnostic agreement between outside labs and an expert center is low (as low as 28% at private clinics vs about 70% at the expert center) and expert second opinion confirmed or improved the correct primary diagnosis in 73% of cases.
  2. 2.Kronz JD, Westra WH, Epstein JI (1999). Mandatory second opinion surgical pathology at a large referral hospital. Cancer. doi:10.1002/(SICI)1097-0142(19991201)86:11<2426::AID-CNCR34>3.0.CO;2-3 ✓That mandatory re-review of more than 6,000 outside surgical-pathology slides changed the diagnosis in a way of major clinical importance (altering therapy or prognosis) in 1.4% of cases.
  3. 3.Ulaner GA, Mannelli L, Dunphy M (2017). Value of second-opinion review of outside institution PET-CT examinations. Nuclear Medicine Communications. doi:10.1097/MNM.0000000000000647 ✓That imaging is re-read too: subspecialist second-opinion review of 240 outside FDG PET-CT examinations produced at least one discordant opinion of malignancy in about 13%, and where a definitive diagnosis was later available the subspecialist read was correct in 25 of 28 (89%).
  4. 4.American Cancer Society (2024). Seeking a Second Opinion. American Cancer Society (cancer.org). link ✓That seeking a second opinion is a normal, expected part of cancer care that most physicians support (addressing the fear of offending the treating doctor), and that patients are entitled to copies of their records and pathology materials.
  5. 5.Matasar MJ, Shi W, Silberstien J, et al. (2012). Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classification. Annals of Oncology. doi:10.1093/annonc/mdr029That the chance of a changed diagnosis rises with how unusual the tissue is: expert re-review of lymphoma yielded a major diagnostic revision in roughly one in six cases overall, with discrepancy reaching about 75% for some subtypes such as Burkitt lymphoma.
  6. 6.Lipitz-Snyderman A, et al. (2023). Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations. Cancer Medicine. doi:10.1002/cam4.5598 ✓That oncology second opinions frequently change management even when the diagnosis is confirmed: 35% of 120 newly diagnosed cases had a clinically meaningful change, most of which occurred even when the original diagnosis was unchanged.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library